IL159219A0 - Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL159219A0
IL159219A0 IL15921902A IL15921902A IL159219A0 IL 159219 A0 IL159219 A0 IL 159219A0 IL 15921902 A IL15921902 A IL 15921902A IL 15921902 A IL15921902 A IL 15921902A IL 159219 A0 IL159219 A0 IL 159219A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
oxadiazole derivatives
pyrrolidine oxadiazole
Prior art date
Application number
IL15921902A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL159219A0 publication Critical patent/IL159219A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
IL15921902A 2001-06-18 2002-06-14 Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them IL159219A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01113632 2001-06-18
PCT/EP2002/006629 WO2002102799A2 (en) 2001-06-18 2002-06-14 Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists

Publications (1)

Publication Number Publication Date
IL159219A0 true IL159219A0 (en) 2004-06-01

Family

ID=8177641

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15921902A IL159219A0 (en) 2001-06-18 2002-06-14 Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them

Country Status (27)

Country Link
US (2) US7115639B2 (pt)
EP (1) EP1444225B1 (pt)
JP (1) JP4426284B2 (pt)
KR (1) KR20040030678A (pt)
CN (1) CN100564378C (pt)
AR (1) AR036108A1 (pt)
AU (1) AU2002319237B2 (pt)
BG (1) BG108424A (pt)
BR (1) BR0211030A (pt)
CA (1) CA2449578C (pt)
CZ (1) CZ20033475A3 (pt)
EA (1) EA006212B1 (pt)
EE (1) EE200400022A (pt)
ES (1) ES2397305T3 (pt)
HK (1) HK1074204A1 (pt)
HR (1) HRP20031017A2 (pt)
HU (1) HUP0400238A2 (pt)
IL (1) IL159219A0 (pt)
MX (1) MXPA03011441A (pt)
MY (1) MY128890A (pt)
NO (1) NO20035399L (pt)
PL (1) PL367275A1 (pt)
RS (1) RS99503A (pt)
SK (1) SK15552003A3 (pt)
UA (1) UA75145C2 (pt)
WO (1) WO2002102799A2 (pt)
ZA (1) ZA200309402B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL159219A0 (en) 2001-06-18 2004-06-01 Applied Research Systems Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
WO2004076407A2 (en) * 2003-02-27 2004-09-10 Applied Research Systems Ars Holding N.V. Pyrrolidine derivatives as oxytocin antagonists
SI1725526T1 (sl) * 2004-02-26 2008-04-30 Serono Lab Postopek priprave pirolidoin-oksimov
KR101386494B1 (ko) 2005-05-10 2014-04-24 인사이트 코포레이션 인돌아민 2,3-디옥시게나제의 조절제 및 이의 사용방법
JP5294874B2 (ja) 2005-12-20 2013-09-18 インサイト・コーポレイション インドールアミン２，３−ジオキシゲナーゼのモジュレーターとしてのｎ−ヒドロキシアミジノヘテロ環
WO2008036642A2 (en) 2006-09-19 2008-03-27 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
CL2007002650A1 (es) 2006-09-19 2008-02-08 Incyte Corp Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras.
KR101649548B1 (ko) 2008-07-08 2016-08-19 인사이트 홀딩스 코포레이션 인돌아민 ２,３-디옥시게나아제의 억제제로서의 １,２,５-옥사디아졸
EP2845850A1 (en) * 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
MX366874B (es) 2013-11-08 2019-07-29 Incyte Holdings Corp Proceso para la síntesis de un inhibidor de indolamina 2,3-dioxigenasa.
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
MX371068B (es) 2014-07-02 2020-01-15 ObsEva SA ((3z,5s)-5-(hidroximetil)-1-[(2'-metil-1,1'-bifenil-4-il)carbonil ]pirrolidin-3-ona o-metiloxima cristalina y métodos de uso de la misma.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722190B1 (fr) * 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
EP0805681A4 (en) 1995-01-24 1998-05-06 Merck & Co Inc TOCOLYTIC ANTAGONISTS OF OXYTOCIN RECEPTORS
US5756497A (en) 1996-03-01 1998-05-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
FR2757157B1 (fr) * 1996-12-13 1999-12-31 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
JP2002543129A (ja) 1999-05-05 2002-12-17 メルク エンド カムパニー インコーポレーテッド 抗微生物剤としての新規なプロリン類
BR0109900A (pt) 2000-03-27 2003-06-03 Applied Research Systems Derivados de pirolidina farmaceuticamente ativos, uso de derivados de pirolidina, composição farmacêutica e processo para preparação de um derivado de pirolidina
IL151911A0 (en) * 2000-03-27 2003-04-10 Applied Research Systems Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them
DE60141849D1 (de) * 2000-10-17 2010-05-27 Merck Serono Sa Coinsins Pharmazeutisch aktive sulfonamid-derivate
AU2002256685B2 (en) * 2001-03-20 2008-01-24 Merck Serono Sa Pyrrolidine ester derivatives with oxytocin modulating acitvity
IL159219A0 (en) 2001-06-18 2004-06-01 Applied Research Systems Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
ES2249636T3 (es) * 2001-12-20 2006-04-01 Applied Research Systems Ars Holding N.V. Triazoles como antagonistas de la oxitocina.
UA78058C2 (en) * 2002-07-05 2007-02-15 Applied Research Systems Pyrrolidine derivative as oxitocin antagonists

Also Published As

Publication number Publication date
JP4426284B2 (ja) 2010-03-03
NO20035399L (no) 2004-02-17
CA2449578C (en) 2011-12-13
US20040220238A1 (en) 2004-11-04
RS99503A (en) 2006-12-15
KR20040030678A (ko) 2004-04-09
WO2002102799A3 (en) 2003-04-03
ES2397305T3 (es) 2013-03-06
HUP0400238A2 (hu) 2004-07-28
EP1444225A2 (en) 2004-08-11
US20060229343A1 (en) 2006-10-12
CZ20033475A3 (en) 2004-05-12
MXPA03011441A (es) 2004-07-01
AU2002319237B2 (en) 2008-01-03
BG108424A (en) 2005-03-31
CA2449578A1 (en) 2002-12-27
HK1074204A1 (en) 2005-11-04
MY128890A (en) 2007-02-28
BR0211030A (pt) 2004-06-22
EE200400022A (et) 2004-04-15
NO20035399D0 (no) 2003-12-04
US7115639B2 (en) 2006-10-03
UA75145C2 (en) 2006-03-15
AR036108A1 (es) 2004-08-11
ZA200309402B (en) 2004-12-03
EA200400049A1 (ru) 2004-08-26
CN100564378C (zh) 2009-12-02
CN1639155A (zh) 2005-07-13
HRP20031017A2 (en) 2004-04-30
WO2002102799A2 (en) 2002-12-27
SK15552003A3 (sk) 2004-05-04
EA006212B1 (ru) 2005-10-27
JP2004534804A (ja) 2004-11-18
EP1444225B1 (en) 2012-10-10
PL367275A1 (en) 2005-02-21

Similar Documents

Publication Publication Date Title
DZ3313A1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
IL151209A0 (en) Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
HUP0400636A3 (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
HUP0400467A3 (en) 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
HUP0400451A3 (en) Pyrrole derivatives and pharmaceutical compositions containing them
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
IL154965A0 (en) Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
HUP0300207A3 (en) 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
HUP0500024A3 (en) 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
IL151912A0 (en) Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them
HUP0400156A3 (en) Pyrrolidine derivatives as factor xa inhibitors, their preparation and pharmaceutical compositions containing them
IL159219A0 (en) Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
IL154966A0 (en) Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
HUP0400154A3 (en) Heterocondesated benzoxazepine and benzoxathiazepine derivatives, their use and pharmaceutical compositions containing them
HK1052168A1 (en) N-deacetylthiocolchincine derivatives and pharmaceutical compositions containing them.
SI1245565T1 (en) Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0402600A3 (en) D-proline derivatives and pharmaceutical compositions containing them